Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 2
2010 3
2012 1
2013 1
2014 1
2015 2
2018 2
2019 4
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Moore KN, Secord AA, Geller MA, Miller DS, Cloven N, Fleming GF, Wahner Hendrickson AE, Azodi M, DiSilvestro P, Oza AM, Cristea M, Berek JS, Chan JK, Rimel BJ, Matei DE, Li Y, Sun K, Luptakova K, Matulonis UA, Monk BJ. Moore KN, et al. Among authors: matei de. Lancet Oncol. 2019 May;20(5):636-648. doi: 10.1016/S1470-2045(19)30029-4. Epub 2019 Apr 1. Lancet Oncol. 2019. PMID: 30948273 Clinical Trial.
Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells.
Rosser EC, Piper CJM, Matei DE, Blair PA, Rendeiro AF, Orford M, Alber DG, Krausgruber T, Catalan D, Klein N, Manson JJ, Drozdov I, Bock C, Wedderburn LR, Eaton S, Mauri C. Rosser EC, et al. Among authors: matei de. Cell Metab. 2020 Apr 7;31(4):837-851.e10. doi: 10.1016/j.cmet.2020.03.003. Epub 2020 Mar 25. Cell Metab. 2020. PMID: 32213346 Free PMC article.
CD73: an emerging checkpoint for cancer immunotherapy.
Chen S, Wainwright DA, Wu JD, Wan Y, Matei DE, Zhang Y, Zhang B. Chen S, et al. Among authors: matei de. Immunotherapy. 2019 Aug;11(11):983-997. doi: 10.2217/imt-2018-0200. Epub 2019 Jun 21. Immunotherapy. 2019. PMID: 31223045 Free PMC article.
Endoglin for targeted cancer treatment.
Rosen LS, Gordon MS, Robert F, Matei DE. Rosen LS, et al. Among authors: matei de. Curr Oncol Rep. 2014 Feb;16(2):365. doi: 10.1007/s11912-013-0365-x. Curr Oncol Rep. 2014. PMID: 24445497 Review.
Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors.
Chiorean EG, Perkins SM, Strother RM, Younger A, Funke JM, Shahda SG, Hahn NM, Sandrasegaran K, Jones DR, Skaar TC, Schneider BP, Sweeney CJ, Matei DE. Chiorean EG, et al. Among authors: matei de. Mol Cancer Ther. 2020 Oct;19(10):2155-2162. doi: 10.1158/1535-7163.MCT-20-0277. Epub 2020 Aug 26. Mol Cancer Ther. 2020. PMID: 32847973 Free PMC article.
Minireview: epigenetic changes in ovarian cancer.
Balch C, Fang F, Matei DE, Huang TH, Nephew KP. Balch C, et al. Among authors: matei de. Endocrinology. 2009 Sep;150(9):4003-11. doi: 10.1210/en.2009-0404. Epub 2009 Jul 2. Endocrinology. 2009. PMID: 19574400 Free PMC article. Review.
Role of epigenomics in ovarian and endometrial cancers.
Balch C, Matei DE, Huang TH, Nephew KP. Balch C, et al. Among authors: matei de. Epigenomics. 2010 Jun;2(3):419-47. doi: 10.2217/epi.10.19. Epigenomics. 2010. PMID: 22121902 Free article. Review.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page